Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Russian attack on Ukraine's Odesa region killed two people, injured three
Duterte was 'pivotal' in murder of thousands, ICC prosecutors say
Powerful winter storm shuts schools, disrupts travel across US Northeast
At least 19 killed in Nepal bus crash
Human rights are under assault, says UN Secretary General
